Endocrine disruptors (restriction list)

As of May 9, 2022, we have a new restriction list in iChemistry: Endocrine disruptors. The list is provided as standard for all customers operating in the EU.

If a product is on the list because it contains an endocrine disruptor, try to substitute the product if possible. Endocrine disruptors are defined as SVHCs (substances of very high concern). SVHC substances first end up on the candidate list, then they can also be included on the Authorisation list, Annex XIV to the REACH Regulation.

For chemical products containing endocrine disruptors (substances on the candidate list), a permit is required in some cases for the product to be handled. By substituting, you therefore do not have to worry about a complicated and costly permit process. There are also requirements that information on endocrine disruptors must be stated in safety data sheets.


"We use products that match the list in iChemistry - what to do?"


If you see that you have products inventoried in iChemistry that match the list of endocrine disruptors, you can start by examining which substance is causing the matching and in what concentration that substance is in the product.

To do this, go to the product's iSafe> Restriction and Prohibition Lists and see the substance name under Reason. Then click on Show composition (or section 3 in the SDS) to see the concentration level for that substance. This way you see if the substance that causes the matching is present in high concentrations in your chemical product or not.

Now that you have identified the product, the substance and the concentration of the substance, you can decide on the following:

  • Substitution

    What do we use the product for, and do we need a chemical product for this purpose or can we adapt our working method so that the need for a chemical product is reduced? If a chemical product is needed; Are there replacement products with less risk of exposure to endocrine disruptors?


  • Adjust your risk assessment

    How can we reduce the risk of harmful exposure? How is the product applied and handled? Can we reduce the amount of product handled per occasion? What protective equipment is required? Review a current risk assessment and redo it if necessary.


  • Pregnant and breastfeeding

    If you have colleagues / employees who are pregnant or breastfeeding, it is extra important to adapt the risk assessment to these people so that they are not exposed to endocrine disruptors.


  • Knowledge

    Make sure that those who handle endocrine disruptors know that the product is endocrine disrupting during exposure and make sure they have the knowledge and conditions they need to protect themselves against exposure.

Did you find it helpful? Yes No

Send feedback
Sorry we couldn't be helpful. Help us improve this article with your feedback.